微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 58.33% | 4.89% | 3.91% | 49/159 | 50.16% | 迪哲医药 | 99.22% | 行业排名> |
| 2026-06-30 | 56.14% | 3.69% | -10.73% | 58/159 | 48.66% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 62.88% | 2% | 16.32% | 47/159 | 50.28% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 54.06% | -4.6% | -2.79% | 67/159 | 50.37% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 55.61% | -9.45% | 2.71% | 62/159 | -2.13% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 54.14% | -12.15% | -12.18% | 68/159 | 15.05% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 61.65% | -2.41% | 8.8% | 43/159 | 31.79% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 56.66% | -6.5% | -7.73% | 62/159 | 51.61% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 61.41% | -1.74% | -0.36% | 48/159 | 22.43% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 61.63% | -2.89% | -2.44% | 48/159 | 32.96% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 63.17% | -2.84% | 4.24% | 42/159 | 51.47% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 60.6% | 4.11% | -3.02% | 51/159 | 51.31% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 62.49% | 8.57% | -1.53% | 47/159 | 32.31% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 63.46% | 10.32% | -2.39% | 49/159 | 38.22% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 65.02% | 2.12% | 11.69% | 40/159 | 52.66% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 58.21% | 16.14% | 1.13% | 62/159 | 53.51% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 57.56% | 12.84% | 0.06% | 62/159 | 5.67% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 57.53% | 14.01% | -9.64% | 65/159 | 20.91% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 63.67% | 55.12% | 27.02% | 47/159 | 54.06% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 50.12% | -8.58% | -1.75% | 84/159 | 54.9% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 51.01% | 27.34% | 1.1% | 70/159 | 46.49% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 50.46% | -9.68% | -7.97% | 77/159 | 46.97% | 艾力斯 | 98.7% | 行业排名> |
| 2020-12-31 | 54.82% | 28.93% | -1.86% | 70/159 | -147.51% | 艾力斯 | 99.4% | 行业排名> |
| 2020-06-30 | 55.86% | 32.43% | 31.38% | 60/159 | 53.85% | 首药控股 | 99.94% | 行业排名> |
| 2019-12-31 | 42.52% | -5.01% | 6.14% | 92/159 | -1232.76% | 泽璟制药 | 99.96% | 行业排名> |
| 2019-09-30 | 40.06% | 2% | -5.04% | 77/159 | 54.86% | 微芯生物 | 95.14% | 行业排名> |
| 2019-06-30 | 42.19% | 2% | 2.78% | 76/159 | 54.88% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-03-31 | 41.04% | 2% | -8.31% | 72/159 | 50.75% | 微芯生物 | 95.81% | 行业排名> |
| 2018-12-31 | 44.76% | 2% | 2% | 79/159 | -210.26% | 微芯生物 | 96.09% | 行业排名> |